COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 335.3 | 3 | 0187-0382 | 792.69 | 380.81 | 322 | 71.84 | 0.784 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 357.0 | 3 | 0188-0387 | 381.32 | 386.98 | 316 | 72.77 | 0.750 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2059.9 | 3 | 0189-0390 | 610.76 | 389.98 | 481 | 86.33 | 0.811 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1330.1 | 3 | 0190-0389 | 695.86 | 388.97 | 303 | 68.43 | 0.813 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 393.8 | 3 | 0191-0392 | 841.59 | 392.05 | 299 | 65.94 | 0.864 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 839.2 | 3 | 0192-0394 | 134.16 | 394.28 | 212 | 54.53 | 0.896 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2698.8 | 3 | 0193-0398 | 670.63 | 398.30 | 256 | 59.11 | 0.921 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2241.6 | 3 | 0194-0402 | 272.23 | 402.84 | 428 | 76.91 | 0.909 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 402.8 | 3 | 0195-0408 | 507.87 | 407.51 | 311 | 66.53 | 0.883 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 339.1 | 3 | 0196-0410 | 807.87 | 410.34 | 346 | 69.84 | 0.891 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 505.9 | 3 | 0197-0409 | 472.96 | 409.63 | 281 | 61.60 | 0.931 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 483.1 | 3 | 0198-0411 | 322.05 | 410.94 | 282 | 63.84 | 0.869 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 373.8 | 3 | 0199-0413 | 571.30 | 413.44 | 318 | 66.53 | 0.903 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 342.7 | 3 | 0200-0414 | 759.60 | 414.30 | 348 | 71.84 | 0.847 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 391.5 | 3 | 0201-0414 | 89.37 | 414.72 | 261 | 60.18 | 0.906 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 881.5 | 3 | 0202-0417 | 190.24 | 417.81 | 315 | 66.77 | 0.888 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 387.7 | 3 | 0203-0419 | 20.26 | 419.74 | 274 | 65.36 | 0.806 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 380.1 | 3 | 0204-0425 | 422.94 | 424.10 | 347 | 74.43 | 0.787 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 498.9 | 3 | 0205-0422 | 719.69 | 422.40 | 292 | 65.36 | 0.859 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2414.0 | 3 | 0206-0425 | 354.68 | 425.44 | 306 | 65.60 | 0.894 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2726.6 | 3 | 0207-0429 | 315.29 | 430.42 | 404 | 77.50 | 0.845 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 423.9 | 3 | 0208-0427 | 212.29 | 427.79 | 284 | 63.94 | 0.873 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 325.5 | 3 | 0209-0429 | 585.97 | 429.94 | 328 | 67.01 | 0.918 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 387.0 | 3 | 0210-0432 | 39.94 | 432.05 | 266 | 62.77 | 0.848 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 757.1 | 3 | 0211-0433 | 109.61 | 432.71 | 202 | 55.11 | 0.836 |